We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Heart Disease Causes Long-Term Brain Damage Following Bypass Surgery

By HospiMedica International staff writers
Posted on 18 Aug 2009
A new study suggests that long-term memory losses and cognitive problems experienced by heart bypass surgery patients are due to the underlying coronary artery disease (CAD) itself, and not ill after-effects from having used a heart-lung machine.

Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA) conducted a prospective, nonrandomized, longitudinal study that compared cognitive outcomes after on-pump coronary artery bypass surgery (152 patients); off-pump bypass surgery patients (75 patients); nonsurgical cardiac comparison subjects who opted for drugs and arterial stents to keep their blood vessels open instead of bypass, with none requiring use of a heart-lung device (99 patients); and 69 heart-healthy comparison (HHC) subjects. More...
The primary outcome measure was change from baseline to 72 months in cognitive domains that included verbal memory, visual memory, visuoconstruction, language, motor speed, psychomotor speed, attention, executive function, and a composite global score.

The study results showed that there were no consistent differences in 72-month cognitive outcomes among the three groups with CAD. The CAD groups had lower baseline performance, and a greater degree of decline compared with HHC. The degree of change was small, and none of the groups was substantially worse at 72 months compared with baseline. According to the researchers, the results indicate that management strategy for CAD is not an important determinant of long-term cognitive outcomes. The study was published in the August 2009 issue of Annals of Thoracic Surgery.

"Our results hammer home the message that heart-lung machines are not to be blamed for cognitive declines observed years later in people who have had bypass surgery,” said lead study investigator Ola Selnes, Ph.D., a professor in the division of cognitive neuroscience in the neurology department at JHU.

Postperfusion syndrome, also known as "pumphead syndrome,” is a constellation of neurocognitive impairments attributed to cardiopulmonary bypass (CPB) during cardiac surgery. The symptoms of postperfusion syndrome are subtle and include defects associated with attention, concentration, short-term memory, fine motor function, and speed of mental and motor responses. The short-term syndrome led many surgeons and patients alike to assume that long-term losses must also be due to use of heart-lung machines, an assumption proven wrong by the latest evidence.

Related Links:
Johns Hopkins University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.